本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SAB Biotherapeutics, Inc.

3.41
-0.0500-1.45%
成交量:17.15萬
成交額:58.03萬
市值:3.10億
市盈率:-2.19
高:3.51
開:3.45
低:3.33
收:3.46
52周最高:5.15
52周最低:1.85
股本:9,098.64萬
流通股本:6,204.34萬
量比:0.80
換手率:0.28%
股息:- -
股息率:- -
每股收益(TTM):-1.5562
每股收益(LYR):-0.7944
淨資產收益率:-11.27%
總資產收益率:-33.46%
市淨率:1.44
市盈率(LYR):-4.29

資料載入中...

2022/03/29

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/10

重要事件披露

8-K - Current report
2022/01/06

重要事件披露

8-K - Current report
2021/12/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/11/22

重要事件披露

8-K - Current report
2021/11/22

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/22

重要事件披露

8-K/A [Amend] - Current report
2021/11/19

重要事件披露

8-K - Current report
2021/11/02

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/10/28

重要事件披露

8-K - Current report
2021/10/22

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/10/21

重要事件披露

8-K - Current report
2021/10/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/13

重要事件披露

8-K - Current report